IntuitionLabs
LabWare LIMS GxP validation documentation and compliance artifacts for pharmaceutical quality control

LabWare LIMS GxP Validation & Compliance

21 CFR Part 11, EU Annex 11, GAMP 5 Second Edition, and ALCOA+ data integrity for LabWare LIMS, ELN, and SAPPHIRE. IQ/OQ/PQ, interface validation, periodic review, and AI-component validation — built for pharmaceutical audit.

Our LabWare Validation Services

We deliver full-lifecycle GxP validation for LabWare deployments — from initial validation of new implementations, through change control and periodic review, to validation of AI components and integrations under GAMP 5 Second Edition.

Regulatory
21 CFR Part 11 & Annex 11
Full mapping of LabWare technical controls to 21 CFR Part 11 and EU Annex 11 clauses, with traceability matrix, configuration evidence, and procedural controls ready for FDA, MHRA, and EMA inspection.
Learn about Part 11
GAMP 5
IQ/OQ/PQ Execution
Templated validation packages aligned with GAMP 5 Second Edition. Risk-based protocols, traceable test scripts, and qualification execution that compresses effort by 40 to 60 percent vs. ground-up approaches.
View CSV services
Data Integrity
ALCOA+ & Inspection Readiness
Data integrity assessments and remediation aligned with MHRA, FDA, and WHO guidance. Audit trail configuration, shadow-data elimination, and inspection-readiness dry runs.
Book assessment

Designed for Regulated QC from the Ground Up

LabWare’s design assumes GxP use. Tamper-evident audit trails, electronic signatures with identity and meaning linkage, versioned Master Data, and segregation-of-duties controls are core to the product, not optional add-ons. That makes LabWare a strong foundation for 21 CFR Part 11 compliance — but the platform’s capabilities only translate into a compliant deployment when configuration, SOPs, training, and validation artifacts are built properly around them.

Regulatory compliance framework for LabWare LIMS in a pharmaceutical quality control laboratory

GAMP 5 Second Edition as the Backbone

Our validation approach is built on ISPE GAMP 5 Second Edition, which modernizes the framework for SaaS systems, agile delivery, AI components, and critical thinking-based validation. LabWare is typically validated as a Category 4 (configured product) system, with Category 5 (custom) components for LabWare Basic scripts, custom reports, and integration adapters. Our risk-based protocols focus qualification effort where it matters most.

GAMP 5 Second Edition validation framework applied to LabWare LIMS deployment

Data Integrity Beyond the Audit Trail

Data integrity is the number-one regulatory focus in pharmaceutical QC, and it extends far beyond audit trail configuration. We build data integrity into every layer of the LabWare deployment: user access governance, shadow-data elimination, validated instrument interfaces, and periodic data integrity review aligned with MHRA, FDA, and WHO guidance.

Pharmaceutical data integrity controls applied across LabWare LIMS and integrated instrument systems

Our Validation Deliverables

Validation Plan & URS

Overall validation strategy plus a User Requirements Specification that captures business needs in testable, traceable language — the foundation of every downstream artifact.

Discuss scope

Risk Assessment

Formal risk assessment using GAMP 5 risk classification, focusing qualification effort on high-risk functions and identifying procedural controls for medium and low-risk areas.

View CSV

IQ / OQ / PQ Protocols

Installation, Operational, and Performance Qualification protocols with traceable test scripts. Templated starting points derived from prior engagements cut effort 40 to 60 percent.

Request sample

Interface Specifications

Dedicated Interface Specifications for SAP, MES, QMS, and instrument integrations — with positive, negative, and edge-case tests plus reconciliation evidence.

Integration services

Part 11 & Annex 11 Matrix

Explicit traceability matrices mapping each 21 CFR Part 11 and EU Annex 11 clause to LabWare configuration, SOPs, training, and validation artifacts — inspector-ready.

Learn about Part 11

Periodic Review Procedures

Annual periodic review procedures and templates aligned with Annex 11 clause 11 and FDA data integrity expectations, deliverable as managed service for clients without validation staff.

Managed services

Today's business insights

Profitable growth in the AI solutions industry

Our CEO discusses how AI is transforming the pharmaceutical industry and shares key strategies for leveraging AI in drug discovery and development.

More insights on unlock profitable growth in ai solutions
Profitable growth in the AI solutions industry

Inspection Readiness as an Ongoing Posture

Inspection readiness is not something you achieve the week before an audit — it is an ongoing posture. We help clients maintain continuous inspection readiness through quarterly audit trail review sampling, quarterly user access recertification, annual periodic review, mock inspections that simulate FDA pharmaceutical quality lines of inquiry, and remediation of findings before they become actual inspection observations.

Pharmaceutical inspection readiness dashboard for LabWare LIMS with continuous compliance monitoring

Global Harmonization for Multi-Site Deployments

For organizations operating multiple manufacturing sites, harmonized validation is a force multiplier. A template validation package executed once and then propagated site-by-site with targeted site-specific qualification reduces per-site effort by 60 to 80 percent. We design the template to satisfy FDA, EMA, PMDA, TGA, and NMPA expectations, with site-level flexibility where local regulations require.

Multi-site global harmonized validation strategy for LabWare LIMS deployments across regulated pharmaceutical manufacturing

Supplier Quality Assessment for LabWare SAPPHIRE

For SaaS deployments, EU Annex 11 clause 3 requires a formal assessment of the supplier’s quality system. We execute this assessment for LabWare SAPPHIRE clients, covering the LabWare development and operations quality system, platform change management, incident response, and the underlying AWS infrastructure compliance posture. The resulting assessment plus the customer-side validation package constitute a complete compliance picture.

Supplier quality assessment for LabWare SAPPHIRE cloud platform on AWS infrastructure

Regulatory Frameworks We Cover

🇺🇸

FDA 21 CFR Part 11

Full clause mapping, technical controls, procedural controls, and inspector-ready traceability matrix for all applicable Part 11 requirements.

🇪🇺

EU GMP Annex 11

Dedicated Annex 11 matrix covering all 17 clauses from risk management through business continuity, with supplier assessment for SaaS.

🌍

ICH Q7, Q8, Q9, Q10

Quality system alignment with ICH quality guidelines, including risk management per Q9(R1) and pharmaceutical quality system per Q10.

📘

ISPE GAMP 5 2nd Ed

Category-based risk approach, software lifecycle alignment, and modern critical-thinking validation per GAMP 5 Second Edition.

🛡️

MHRA & WHO DI

Data integrity posture aligned with MHRA GXP data integrity guidance and WHO good data and record management practices.

🌐

PMDA, TGA, NMPA

Regional regulator alignment for Japan, Australia, and China to support global pharmaceutical manufacturers with multi-regional validation.

Our Validation Methodology

IntuitionLabs delivers LabWare validation using a phased, risk-based methodology aligned with GAMP 5 Second Edition. Our approach compresses effort through templating and automation without compromising the rigor that FDA, MHRA, and EMA inspectors expect.

Assess & Plan

Gap assessment, validation strategy, URS, and risk-based scope definition — typically 3 to 5 weeks.

Execute

IQ/OQ/PQ execution, interface validation, traceability matrix build-out — typically 8 to 12 weeks.

Sustain

Periodic review, change control, incident response, and inspection readiness as ongoing managed service.

Frequently Asked Questions

Under ISPE GAMP 5 Second Edition, LabWare LIMS is typically classified as a Category 4 (configurable product) system — a commercial software package that is extensively configured rather than custom-coded. Workflows, Master Data, forms, and report templates are configurations; custom LabWare LIMS Basic scripts and integration adapters are Category 5 (custom) components within the overall system. IntuitionLabs delivers a risk-based validation approach: we write a User Requirements Specification, a Functional Specification that maps requirements to LabWare functionality, a Design Specification for customizations, and Installation / Operational / Performance Qualification documents with test scripts traceable to requirements. Our templated validation package cuts effort by 40 to 60 percent compared to ground-up validation, while maintaining the documentation rigor that FDA, MHRA, and EMA inspectors expect.
21 CFR Part 11 requires that electronic records are trustworthy, reliable, and generally equivalent to paper records, and that electronic signatures are linked to the signer and carry a meaning. LabWare provides the technical controls to satisfy each requirement: secure authentication with password complexity and expiration, session timeout, role-based access with segregation of duties, complete tamper-evident audit trails on every transaction (who changed what, when, and why), electronic signatures with identity and meaning linkage, time-stamped record versioning, and the ability to generate accurate and complete copies in human-readable and electronic form. Achieving compliance is not automatic — it requires proper configuration, documented procedures, user training, and periodic review, all of which IntuitionLabs delivers as part of the validation engagement.
EU GMP Annex 11 sets European expectations for computerized systems used in GMP environments. Annex 11 covers risk management, personnel and training, suppliers and service providers, validation, data storage and backup, printouts, audit trails, change and configuration management, periodic evaluation, security, incident management, electronic signatures, and business continuity. LabWare's technical capabilities map directly to these expectations, and our validation deliverables address each clause explicitly. We produce a dedicated Annex 11 traceability matrix as part of the validation package so that inspectors can see at a glance how each clause is addressed through a combination of LabWare configuration, SOPs, training records, and validation artifacts. This is particularly important for organizations that market globally and need to satisfy both FDA and EMA expectations.
Data integrity has been a top inspection finding theme across FDA, MHRA, and WHO inspections for the past decade. The baseline expectation is the ALCOA+ framework — data must be Attributable, Legible, Contemporaneous, Original, and Accurate, plus Complete, Consistent, Enduring, and Available. MHRA's data integrity guidance, FDA's data integrity guidance, and WHO's good data and record management practices set specific expectations. IntuitionLabs builds data integrity into every layer of the LabWare deployment: audit trail configuration, user access governance, shadow-data elimination (no more spreadsheet-based calculations outside the LIMS), validated instrument integration, and periodic data integrity reviews. We also implement automated data integrity monitoring dashboards that surface anomalies — unexpected manual overrides, unusual access patterns, or gaps in expected data flow — before they become inspection findings.
A complete LabWare validation package includes a Validation Plan describing the overall approach and scope, a User Requirements Specification capturing what the business needs, a Functional Specification mapping requirements to LabWare capabilities, a Design Specification for customizations and integrations, a formal Risk Assessment using GAMP 5 risk classification, Installation Qualification verifying correct installation in each environment, Operational Qualification verifying each function works as specified, Performance Qualification demonstrating end-to-end processes meet user requirements in production conditions, a Traceability Matrix linking every requirement to tests and design elements, a Validation Summary Report, and ongoing deliverables including periodic review, change control procedures, and incident response procedures. We deliver all of these using templated starting points derived from prior engagements, which dramatically accelerates the project while preserving the rigor that GAMP 5 expects.
Each instrument interface is validated as a distinct interface under GAMP 5. For chromatography data systems like Waters Empower, Thermo Chromeleon, and Agilent OpenLab CDS, the interface specification documents the worklist download, result upload, user identity propagation, error handling, and reconciliation approach. Operational Qualification tests positive flows, negative flows (rejected results, analyst mismatch, method mismatch), and edge cases. Performance Qualification demonstrates the interface working in production-like conditions with real instrument data. Every interface is periodically reviewed and re-qualified after material changes. This approach aligns with FDA data integrity expectations for regulated laboratory systems.
Validation timelines depend on scope and the quality of inputs. For a single-site LabWare deployment with finished product release, stability, and environmental monitoring, the validation phase typically runs 3 to 5 months and overlaps with configuration and integration work. The dedicated qualification execution window (IQ/OQ/PQ) is usually 6 to 10 weeks. For multi-site rollouts where a template deployment is validated once and then propagated, the per-site validation effort drops dramatically — often to 4 to 6 weeks of site-specific IQ/OQ with targeted PQ on site-unique workflows. We use AI-assisted test script generation, automated test execution where appropriate, and templated documentation to compress these timelines without compromising quality.
A properly validated LabWare deployment is an asset during FDA and MHRA inspections, not a liability. Inspectors frequently request sample pull lists and audit trails for specific batches, stability data trending, deviation and OOS histories, and evidence of periodic review. LabWare's native reporting engine plus our analytics layer can respond to inspection requests in minutes rather than hours. IntuitionLabs helps organizations prepare for inspections by running mock inspections that simulate common FDA, MHRA, and EMA lines of inquiry, reviewing audit trails and data integrity posture, and identifying and remediating findings before an actual inspection. We have seen validated LabWare deployments become centerpiece demonstrations of data integrity maturity during FDA pharmaceutical quality assessments.
Change control in a validated LabWare environment follows a structured process aligned with ICH Q10 and GAMP 5. Every change — whether a configuration update, Master Data change, LabWare Basic script modification, integration change, or platform upgrade — goes through a documented lifecycle: change request with impact assessment, risk classification, testing in a qualified development/test environment, approval by the quality unit, deployment with documented evidence, post-deployment verification, and periodic review. We implement this using version-controlled configuration scripts, automated deployment tooling, and CI/CD-style quality gates that ensure no change reaches production without the right approvals. The rigor satisfies auditor expectations while preserving the operational agility that modern QC organizations need.
Both FDA data integrity guidance and EU Annex 11 (clause 11) expect periodic evaluation of computerized systems. A LabWare periodic review typically occurs annually and assesses: user access appropriateness (have departed users been deprovisioned? are roles still aligned with duties?), audit trail review sampling (are audit trails being reviewed per SOP? are unexpected manual overrides occurring?), change history summarization (what changes have been made in the period? were all properly controlled?), incident and deviation review, data integrity spot checks, and security posture. IntuitionLabs helps clients build periodic review procedures that are rigorous without being burdensome, and we can deliver periodic review as a managed service for clients without dedicated validation staff. AI-powered analytics over LabWare data dramatically accelerate the evidence-gathering portions of the review.
Integrations between LabWare and SAP S/4HANA or MES platforms like Opcenter Execution Pharma are particularly sensitive because they control batch release status and in-process quality verdicts. Each integration is validated with its own Interface Specification, test scripts covering positive flows, negative flows, error handling, and edge cases, and formal reconciliation between source and target systems over a defined period. We also design operational monitoring — dashboards and alerts that surface message failures, reconciliation gaps, or latency issues in real time, so issues are detected before they impact production. The validation and monitoring approach aligns with FDA data integrity expectations.
Yes. LabWare SAPPHIRE is a SaaS platform running on AWS, and its validation approach differs in important ways from on-premise LabWare. Under GAMP 5 Second Edition's updated guidance for SaaS systems, a shared-responsibility validation model applies: LabWare is responsible for validating platform infrastructure, application code, and deployment pipelines, while the customer is responsible for validating configuration, workflows, Master Data, user access, and use of the platform. IntuitionLabs delivers the customer-side validation package for SAPPHIRE: configuration validation, workflow PQ, Master Data integrity, and integration validation. We also assess the LabWare-provided AWS-based infrastructure package against your internal IT quality standards and document the supplier quality assessment expected by Annex 11 clause 3.
Ready to Validate Your LabWare LIMS Properly?
Ready to Validate Your LabWare LIMS Properly? image

Ready to Validate Your LabWare LIMS Properly?

Book a validation assessment to identify gaps against 21 CFR Part 11, EU Annex 11, and GAMP 5 Second Edition \u2014 and build a validation package that stands up to FDA, MHRA, and EMA inspection while leaving room for AI-enabled innovation.

Book a Meeting

© 2026 IntuitionLabs. All rights reserved.

Privacy PolicyTerms of ServiceBook Meeting